Characterization of a new renal cell carcinoma bone metastasis mouse model

Clinical and Experimental Metastasis

Volumn 27, Issue 5, 2010, Pages 319-330

  Strube, Anne ^a,b   Stepina, Elizaveta ^a   Mumberg, Dominik ^a   Scholz, Arne ^a   Hauff, Peter ^a   Käkönen, Sanna Maria ^a,c,d  

^a BAYER PHARMA AG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF TURKU   (Finland)

^d Amgen AB Finland   (Finland)

Author keywords

786 O; Animal model development; Bone metastasis; In vivo selection; Kidney cancer; Luciferase; Osteolytic bone lesions; Renal cell carcinoma (RCC)

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE DESTRUCTION; BONE METASTASIS; BONE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FORELIMB; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; INOCULATION; KIDNEY CARCINOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY TUMOR; METASTASIS; PATHOLOGY;

ANIMALS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION;

EID: 77953918481     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9329-9     Document Type: Article

References (42)

1. RA Figlin 1999 Renal cell carcinoma: management of advanced disease J Urol 161 2 381 386 10.1016/S0022-5347(01)61897-4 1:STN:280:DyaK1M7ht1Kitg%3D%3D 9915408 (discussion 386-387)
2. J Zekri, et al. 2001 The skeletal metastatic complications of renal cell carcinoma Int J Oncol 19 2 379 382 1:STN:280:DC%2BD3MzptFSmuw%3D%3D 11445855
3. Galasko CS (1981) Bone metastases studied in experimental animals. Clin Orthop Relat Res 155:269-285 (Pubitemid 11145894)
4. A Jemal, et al. 2004 Cancer statistics, 2004 CA Cancer J Clin 54 1 8 29 10.3322/canjclin.54.1.8 14974761 (Pubitemid 38443417)
5. Durr HR et al (1999) Surgical treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 367:283-290 (Pubitemid 29503706)
6. A Iwai, et al. 2004 Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids Mol Cell Endocrinol 226 1-2 11 17 10.1016/j.mce.2004.07.013 1:CAS:528:DC%2BD2cXos1eiur8%3D 15489000 (Pubitemid 39369818)
7. A Takahashi, et al. 1994 Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis Cancer Res 54 15 4233 4237 1:CAS:528:DyaK2cXltVGmt7w%3D 7518352 (Pubitemid 24258135)
8. RJ Motzer P Russo 2000 Systemic therapy for renal cell carcinoma J Urol 163 2 408 417 10.1016/S0022-5347(05)67889-5 1:STN:280:DC%2BD3c7ht1Wluw%3D%3D 10647643 (Pubitemid 30060482)
9. K Weber M Doucet S Kominsky 2007 Renal cell carcinoma bone metastasis-elucidating the molecular targets Cancer Metastasis Rev 26 3-4 691 704 10.1007/s10555-007-9090-y 17768599 (Pubitemid 350115120)
10. SL Kominsky, et al. 2007 TGF-beta promotes the establishment of renal cell carcinoma bone metastasis J Bone Miner Res 22 1 37 44 10.1359/jbmr.061005 1:CAS:528:DC%2BD2sXhtVWntbg%3D 17032147 (Pubitemid 46032595)
11. JH Mydlo, et al. 1989 Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue Cancer Res 49 12 3407 3411 1:CAS:528:DyaL1MXksFGjsrc%3D 2720695 (Pubitemid 19162159)
12. KL Weber, et al. 2002 Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model J Urol 168 2 774 779 10.1016/S0022-5347(05)64743-X 12131367
13. N Takahashi, et al. 1986 Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures J Clin Invest 78 4 894 898 10.1172/JCI112677 1:CAS:528:DyaL28XmtVersro%3D 3489738 (Pubitemid 17177067)
14. J Pan, et al. 2006 Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis Mol Cancer 5 56 10.1186/1476-4598-5-56 17083723 (Pubitemid 44803715)
15. TJ Rosol, et al. 2003 Animal models of bone metastasis Cancer 97 3 Suppl 748 757 10.1002/cncr.11150 12548572
16. F Arguello RB Baggs CN Frantz 1988 A murine model of experimental metastasis to bone and bone marrow Cancer Res 48 23 6876 6881 1:STN:280:DyaL1M%2FivVelsQ%3D%3D 3180096 (Pubitemid 19012221)
17. T Yoneda, et al. 1997 Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2 J Clin Invest 99 10 2509 2517 10.1172/JCI119435 1:CAS:528:DyaK2sXjsVGqt7s%3D 9153295 (Pubitemid 27227730)
18. JJ Yin, et al. 1999 TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development J Clin Invest 103 2 197 206 10.1172/JCI3523 1:CAS:528:DyaK1MXltFeqsQ%3D%3D 9916131
19. RE Coleman 1997 Skeletal complications of malignancy Cancer 80 8 Suppl 1588 1594 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2- G 1:STN:280:DyaK1c%2Fis1Onuw%3D%3D 9362426
20. MI Milowsky DM Nanus 2003 Chemotherapeutic strategies for renal cell carcinoma Urol Clin North Am 30 3 601 609 10.1016/S0094-0143(03)00031-4 12953758 (Pubitemid 37059565)
21. RJ Motzer, et al. 1997 Renal cell carcinoma Curr Probl Cancer 21 4 185 232 10.1016/S0147-0272(97)80007-4 1:STN:280:DyaK2svjtFSrtQ%3D%3D 9285186
22. J Vuky, et al. 2006 Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma Invest New Drugs 24 1 85 88 10.1007/s10637-005-4543-z 1:CAS:528:DC%2BD28XovVCjuw%3D%3D 16380835 (Pubitemid 43163424)
23. BC Leibovich ML Blute 2006 Surgical management of renal cell carcinoma Semin Oncol 33 5 552 562 10.1053/j.seminoncol.2006.06.007 17045084 (Pubitemid 44511977)
24. T Lorincz J Timar M Szendroi 2004 Alterations of microvascular density in bone metastases of adenocarcinomas Pathol Oncol Res 10 3 149 153 10.1007/BF03033743 1:CAS:528:DC%2BD2cXhtVWrsbzI 15448750 (Pubitemid 39421993)
25. IJ Fidler ML Kripke 1977 Metastasis results from preexisting variant cells within a malignant tumor Science 197 4306 893 895 10.1126/science.887927 1:STN:280:DyaE2s3js1Sgsw%3D%3D 887927
26. Y Kang, et al. 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 6 537 549 10.1016/S1535-6108(03)00132-6 1:CAS:528:DC%2BD3sXltlSmsL4%3D 12842083 (Pubitemid 36808649)
27. V Ling, et al. 1985 Quantitative genetic analysis of tumor progression Cancer Metastasis Rev 4 2 173 192 10.1007/BF00050694 1:STN:280: DyaL2M3lsVektQ%3D%3D 3893685
28. HF Dvorak 2002 Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 21 4368 4380 10.1200/JCO.2002.10.088 1:CAS:528:DC%2BD38Xpt1CjtL0%3D 12409337 (Pubitemid 35266299)
29. BI Rini EJ Small 2005 Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma J Clin Oncol 23 5 1028 1043 10.1200/JCO.2005.01.186 1:CAS:528:DC%2BD2MXit1Gnsrs%3D 15534359 (Pubitemid 46202321)
30. M Gorospe, et al. 1999 Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells Mol Cell Biol 19 2 1289 1300 1:CAS:528:DyaK1MXhtVKhtLw%3D 9891063 (Pubitemid 29046871)
31. G Semenza 2002 Signal transduction to hypoxia-inducible factor 1 Biochem Pharmacol 64 5-6 993 998 10.1016/S0006-2952(02)01168-1 1:CAS:528: DC%2BD38Xms1ymsLg%3D 12213597 (Pubitemid 35232274)
32. DJ van Spronsen, et al. 2005 Novel treatment strategies in clear-cell metastatic renal cell carcinoma Anticancer Drugs 16 7 709 717 10.1097/01.cad.0000167901.58877.a3 16027518 (Pubitemid 41104919)
33. H Iguchi, et al. 2002 A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma J Exp Clin Cancer Res 21 3 309 313 1:CAS:528:DC%2BD38XotlGgur0%3D 12385570
34. Q Yang, et al. 2008 VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin Matrix Biol 27 7 589 599 10.1016/j.matbio.2008.06.005 18640270
35. MM Hurley, et al. 1998 Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures Bone 22 4 309 316 10.1016/S8756- 3282(97)00292-5 1:CAS:528:DyaK1cXisVChur4%3D 9556129 (Pubitemid 28177182)
36. TA Guise, et al. 2002 Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo Bone 30 5 670 676 10.1016/S8756-3282(02)00685-3 1:CAS:528:DC%2BD38Xjtl2ltLk%3D 11996903 (Pubitemid 34475098)
37. SM Kakonen GR Mundy 2003 Mechanisms of osteolytic bone metastases in breast carcinoma Cancer 97 3 Suppl 834 839 10.1002/cncr.11132 12548583 (Pubitemid 36125820)
38. B Paule 2001 Interleukin-6 and bone metastasis of renal cancer: molecular bases and therapeutic implications Prog Urol 11 2 368 375 1:STN:280: DC%2BD3Mzjt12ktw%3D%3D 11400511
39. SC Manolagas 1995 Role of cytokines in bone resorption Bone 17 2 Suppl 63S 67S 10.1016/8756-3282(95)00180-L 1:CAS:528:DyaK2MXns1OgsLk%3D 8579900
40. MS Bendre, et al. 2003 Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease Bone 33 1 28 37 10.1016/S8756-3282(03)00086-3 1:CAS:528: DC%2BD3sXmt1KjsLw%3D 12919697 (Pubitemid 36952685)
41. G Girasole, et al. 1994 Interleukin-11: a new cytokine critical for osteoclast development J Clin Invest 93 4 1516 1524 10.1172/JCI117130 1:CAS:528:DyaK2cXis1Oqsbg%3D 8163655 (Pubitemid 24116388)
42. T Yoneda A Sasaki GR Mundy 1994 Osteolytic bone metastasis in breast cancer Breast Cancer Res Treat 32 1 73 84 10.1007/BF00666208 1:STN:280:DyaK2M7hvFCiuw%3D%3D 7819589 (Pubitemid 24322250)